IRM
49
2
CPB
39
2
AMT
30
4
V
52
-2
URBN
51
-3
CVX
29
-2
LYB
23
3
PNW
59
2
PSA
35
-2
AFL
45
-3
ADI
73
-3
EXR
55
31
HSY
47
-3
HPQ
37
2
SIG
47
-2
CA
36
12
MO
48
-9
DIS
70
-2
ROST
68
-2
ADT
50
2
IRM
49
2
CPB
39
2
AMT
30
4
V
52
-2
URBN
51
-3
CVX
29
-2
LYB
23
3
PNW
59
2
PSA
35
-2
AFL
45
-3
ADI
73
-3
EXR
55
31
HSY
47
-3
HPQ
37
2
SIG
47
-2
CA
36
12
MO
48
-9
DIS
70
-2
ROST
68
-2
ADT
50
2
Financhill
Back

Immunome, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
63

IMNM
Immunome, Inc.

Last Price:
$21.70
Seasonality Move:
64.59%

7 Day Trial

ALL ACCESS PASS

$ 7
  • The current trend is moderately bullish and IMNM is experiencing slight selling pressure.

Immunome, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 21.56 Buy
20-day SMA: 20.31 Buy
50-day SMA: 18.17 Buy
200-day SMA: 11.54 Buy
8-day EMA: 21.48 Buy
20-day EMA: 20.44 Buy
50-day EMA: 18.22 Buy
200-day EMA: 13.57 Buy

Immunome, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.18 Buy
Relative Strength Index (14 RSI): 58.17 Buy
Chaikin Money Flow: -90380 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.27 - 21.55) Buy
Bollinger Bands (100): (10.29 - 18.67) Buy

Immunome, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Immunome, Inc. Stock

Is Immunome, Inc. Stock a Buy?

  • Immunome, Inc. share price is 21.71 while IMNM 8-day simple moving average is 21.56, which is a Buy signal.
  • The stock price of IMNM is 21.71 while Immunome, Inc. 20-day SMA is 20.31, which makes it a Buy.
  • Immunome, Inc. 50-day simple moving average is 18.17 while IMNM share price is 21.71, making it a Buy technically.
  • IMNM stock price is 21.71 and Immunome, Inc. 200-day simple moving average is 11.54, creating a Buy signal.

IMNM Technical Analysis vs Fundamental Analysis

Buy
63
Immunome, Inc. (IMNM) is a Buy

Is Immunome, Inc. a Buy or a Sell?

  • Immunome, Inc. stock is rated a Buy
    The current Immunome, Inc. [IMNM] share price is $21.71. The Score for IMNM is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.

Immunome, Inc. Stock Info

Market Cap:
2B
Price in USD:
21.71
Share Volume:
1M

Immunome, Inc. 52-Week Range

52-Week High:
25.30
52-Week Low:
5.15
Buy
63
Immunome, Inc. (IMNM) is a Buy

Immunome, Inc. Share Price Forecast

  • What is the Immunome, Inc. stock price today?
    The Immunome, Inc. stock price is 21.71 USD today.
  • Will IMNM stock go up or go down?
    Immunome, Inc.> share price is forecast to RISE/FALL based on technical indicators
  • Is Immunome, Inc. overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Immunome, Inc. is not overvalued.

Is Immunome, Inc. Stock a Buy?

  • Immunome, Inc. share price is 21.71 while IMNM 8-day exponential moving average is 21.48, which is a Buy signal.
  • The stock price of IMNM is 21.71 while Immunome, Inc. 20-day EMA is 20.44, which makes it a Buy.
  • Immunome, Inc. 50-day exponential moving average is 18.22 while IMNM share price is 21.71, making it a Buy technically.
  • IMNM stock price is 21.71 and Immunome, Inc. 200-day simple moving average is 13.57, creating a Buy signal.

Fundamental Analysis of Immunome, Inc.

Is Immunome, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.95 per share, and a decrease next year of $0.36 per share.

Technical Analysis of Immunome, Inc.

Should I short Immunome, Inc. stock?

* Immunome, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.